Research and Development
Tmunity is developing a diversified portfolio of novel treatments that exhibit best-in-class control over T cell activation and direction in the body. These personalized next-generation immunotherapies for cancer, infectious disease and autoimmune disease are advancing rapidly toward the clinic.
“The controlled activation of T cells in the body holds the key to better treatments for a wide range of devastating human diseases. Our focus at Tmunity is to pursue the implications of this insight and to find ways to accelerate the development of novel T cell therapies that can be routinely delivered in a clinical setting.”